Cost Analysis of Implant-Based Breast Reconstruction With Acellular Dermal Matrix

被引：87

作者：

de Blacam, Catherine ^{[1
]}

Momoh, Adeyiza O. ^{[1
]}

Colakoglu, Salih ^{[1
]}

Slavin, Sumner A. ^{[1
]}

Tobias, Adam M. ^{[1
]}

Lee, Bernard T. ^{[1
]}

机构：

[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Plast & Reconstruct Surg,Dept Surg, Boston, MA 02215 USA

来源：

ANNALS OF PLASTIC SURGERY | 2012年 / 69卷 / 05期

关键词：

breast reconstruction; acellular dermal matrix; breast implants; cost analysis; implant reconstruction; EPIGASTRIC PERFORATOR FLAP; EXPANDER/IMPLANT RECONSTRUCTION; POSTMASTECTOMY RECONSTRUCTION; TISSUE MATRIX; TRAM FLAP; ALLODERM; COVERAGE; SURGERY;

D O I：

10.1097/SAP.0b013e318217fb21

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

A comparative cost analysis of breast reconstruction using acellular dermal matrix (ADM) and traditional tissue expander-/implant-based techniques was carried out. Medicare reimbursement costs were calculated for tissue expander/implant alone (TE/I), TE/I with ADM (TE/I + ADM), and single-stage implant (SSI) with ADM (SSI + ADM). The most expensive procedure at baseline was TE/I + ADM ($11,255.78), followed by TE/I alone ($10,934.18), and SSI + ADM ($5,423.02). Incorporating the probability of complications as derived from the published literature into the cost analysis resulted in an increase in the excess cost of ADM-based procedures (TE/I + ADM, $11,829.02; TE/I, $11,238.60; SSI + ADM, $5,909.83). Although SSI + ADM have the lowest cost, not all patients are suitable candidates for this type of procedure. With increasing focus on healthcare expenditure, it is important that plastic surgeons are aware of the cost implications of using ADM products.

引用

页码：516 / 520

页数：5

共 40 条

[1]

[Anonymous], 2010, 2010 REP 2009 STAT N

[2]

[Anonymous], 2009, Pilot Program for Green Technologies Including Greenhouse Gas Reduction

[3] Acellular Human Dermis Implantation in 153 Immediate Two-Stage Tissue Expander Breast Reconstructions: Determining the Incidence and Significant Predictors of Complications [J].